The cholesterol paradox in atrial fibrillation: results from the LIPIDOGRAM 2015 study

被引：0
|
作者：
Harrison, S. [1 ]
Lip, G. Y. H. [1 ]
Lane, D. A. [1 ]
Mastej, M. [2 ]
Kasperczyk, S. [3 ]
Banach, M. [4 ]
Jozwiak, J. J. [2 ]
机构：
[1] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
[2] Univ Opole, Dept Family Med & Publ Hlth, Opole, Poland
[3] Univ Silesia, Dept Biochem, Katowice, Poland
[4] Univ Lodz, Dept Hypertens, Zeromskiego, Poland
来源：
EUROPEAN HEART JOURNAL | 2020年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：451 / 451
页数：1
相关论文
共 50 条
  • [31] Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: Results from a multicenter study
    Bhargava, Mandeep
    Di Biase, Luigi
    Mohanty, Prasant
    Prasad, Subramanyam
    Martin, David O.
    Williams-Andrews, Michelle
    Wazni, Oussama M.
    Burkhardt, J. David
    Cummings, Jennifer E.
    Khaykin, Yaariv
    Verma, Atul
    Hao, Steven
    Beheiry, Salwa
    Hongo, Richard
    Rossillo, Antonio
    Raviele, Antonio
    Bonso, Aldo
    Themistoclakis, Sakis
    Stewart, Kelly
    Saliba, Walid I.
    Schweikert, Robert A.
    Natale, Andrea
    HEART RHYTHM, 2009, 6 (10) : 1403 - 1412
  • [32] Global Variation in the Etiology and Management of Atrial Fibrillation: Results from a Global Atrial Fibrillation Registry
    Healey, Jeff S.
    Oldgren, Jonas
    Parekh, Amit
    Commerford, Patrick J.
    Avezum, Alvaro
    Pais, Prem
    Zhu, Jun
    Jansky, Petr
    Sigami, Alben
    Morillo, Carlos A.
    Liu, Lisheng
    Damasceno, Albertino
    Grinvalds, Alex
    Reilly, Paul
    Ezekowitz, Michael
    Wallentin, Lars
    Connolly, Stuart J.
    Yusuf, Salim
    CIRCULATION, 2011, 124 (21)
  • [33] The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study
    Jozwiak, Jacek J.
    Studzinski, Krzysztof
    Tomasik, Tomasz
    Windak, Adam
    Mastej, Miroslaw
    Catapano, Alberico L.
    Ray, Kausik K.
    Mikhailidis, Dimitri P.
    Toth, Peter P.
    Howard, George
    Lip, Gregory Y. H.
    Tomaszewski, Maciej
    Charchar, Fadi J.
    Sattar, Naveed
    Williams, Bryan
    MacDonald, Thomas M.
    Nowak, Dariusz
    Skowron, Lukasz
    Kasperczyk, Slawomir
    Banach, Maciej
    ATHEROSCLEROSIS SUPPLEMENTS, 2020, 42 : E15 - E24
  • [34] Atrial fibrillation And primary aldosteronism: results of the papphy study
    Seccia, Teresa M.
    Letizia, Claudio
    Muiesan, Maria Lorenza
    Lerco, Silvia
    Bisogni, Valeria
    Maiolino, Giuseppe
    Cesari, Maurizio
    Rossi, Gian Paolo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0J) : J33 - J34
  • [35] The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study
    Jozwiak, J.
    Studzinski, K.
    Tomasik, T.
    Windak, A.
    Banach, M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2847 - 2847
  • [36] Results of the pilot study of the Canadian trial of atrial fibrillation
    Roy, D
    Talajic, M
    Dubuc, M
    Thibault, B
    CIRCULATION, 1996, 94 (08) : 3894 - 3894
  • [37] Atrial fibrillation in outpatients with stable coronary artery disease: results from the multicenter RECENT study (vol 125, pg 162, 2015)
    Zielonka, A.
    Tkaczyszyn, M.
    Mende, M.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (04): : 308 - 308
  • [38] The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial
    Sandhu, Roopinder K.
    Ezekowitz, Justin
    Andersson, Ulrika
    Alexander, John H.
    Granger, Christopher B.
    Halvorsen, Sigrun
    Hanna, Michael
    Hijazi, Ziad
    Jansky, Petr
    Lopes, Renato D.
    Wallentin, Lars
    EUROPEAN HEART JOURNAL, 2016, 37 (38) : 2869 - 2878
  • [39] Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial-fibrillation: Results from the Canadian Registry of Atrial Fibrillation
    Kerr, CR
    Humphries, KH
    Talajic, M
    Klein, GJ
    Connally, SJ
    Green, M
    Boone, J
    Sheldon, R
    Dorian, P
    Newman, D
    AMERICAN HEART JOURNAL, 2005, 149 (03) : 489 - 496
  • [40] Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation (TAF) study
    Endalkachew Admassie
    Leanne Chalmers
    Luke R. Bereznicki
    European Journal of Clinical Pharmacology, 2017, 73 : 1681 - 1689
12345